13D/13G Filings - X4 Pharmaceuticals Inc (XFOR)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-12
12:39 pm
Sale
2020-12-3113GX4 Pharmaceuticals, Inc.
XFOR
Deerfield Mgmt, L.P.15,250
2.730%
-14,981decrease
(-49.56%)
Filing
History
2021-02-02
3:13 pm
Purchase
2020-12-3113GX4 Pharmaceuticals, Inc.
XFOR
BlackRock Inc.
BLK
34,450
6.300%
34,450increase
(New Position)
Filing
History
2020-12-30
5:26 pm
Purchase
2020-12-2913GX4 Pharmaceuticals, Inc.
XFOR
Ikarian Capital, LLC27,547
5.100%
27,547increase
(New Position)
Filing
History
2020-09-10
10:03 am
Sale
2020-09-0913GX4 Pharmaceuticals, Inc.
XFOR
FMR LLC27,243
4.915%
-17,757decrease
(-39.46%)
Filing
History
Goto Prev, 0, 1, 2